Virologist Beata Halassy, ​​facing a recurrent tumor, develops and tests on herself an innovative therapy: here is her story.

Virologist treats breast cancer with oncolytic virotherapy, shrinking the tumor and boosting immune response. An ...

Imugene stocks well placed to grow with clinical progress on azer-cel CAR T-cell therapy and strong cash position, say analysts ...

A Croatian virologist, Beata Halassy, battling breast cancer recurrence, took a daring step by injecting herself with ...

MB-108 shows activity and is well tolerated in recurrent glioblastoma, with preclinical data supporting its combination with ...

Researchers from Queen Mary University of London, the Chinese Academy of Sciences and Capital Medical University in Beijing ...

Mustang Bio has received orphan drug designation from the US Food and Drug Administration (FDA) for MB-108, a herpes simplex ...

About MB-109 (MB-101 (IL13Rα2 targeted CAR-T cells) + MB-108 oncolytic virus) ...

Clinical-stage immuno-oncology company Imugene is celebrating more than two years’ “complete response” for one of its bile ...

In addition, Imugene has made strides in expanding its trial. The Cohort Review Committee has cleared the first cohort of ...

Under the terms of the manufacturing supply agreement, FUJIFILM Diosynth Biotechnologies will provide secondary US-based ...

Candel Therapeutics aims to revolutionize cancer treatment with oncolytic virus therapy, awaiting crucial trial results in Q4 ...